Step 1 topics → Renal → Loop Diuretics

Loop Diuretics

USMLE Step 1 trap: Confuses loop diuretic target as Na/K-ATPase rather than NKCC2 in the thick ascending limb. Loop diuretics block the Na-K-2Cl cotransporter (NKCC2) on the apical membrane of the thick ascending limb of the loop of Henle.

Loop diuretics — furosemide, bumetanide, torsemide, and ethacrynic acid — are the most powerful diuretics in clinical use, and USMLE Step 1 tests them hard. Their mechanism centers on blocking NKCC2 (the Na-K-2Cl cotransporter) in the thick ascending limb of the loop of Henle. Because the TAL is impermeable to water and responsible for generating the medullary concentration gradient, blocking NKCC2 obliterates that gradient and dumps massive amounts of sodium, water, and other electrolytes into the urine. The exam expects you to trace the downstream consequences of that single mechanism — ionic losses, volume effects, and the clinical situations where those properties become useful or dangerous.

Step 1 tests loop diuretics from three angles: mechanism (what transporter, where, and what ions follow), adverse effects (the classic mnemonic OH DANG: Ototoxicity, Hypokalemia, Dehydration/decreased blood pressure, Allergy, Nephritis interstitial, Gout), and clinical indications (pulmonary edema, hypercalcemia, acute heart failure, edematous states). Passage-based questions often require you to interpret a clinical vignette — a patient on furosemide develops tinnitus after starting gentamicin, or a patient's calcium drops after starting a diuretic — and identify which drug class fits the pattern.

The biggest traps are transporter confusion and calcium handling. Students mix up loop diuretics with thiazides on calcium: thiazides retain calcium, loops waste it. That distinction alone generates multiple question stems. Students also underestimate ototoxicity — especially missing that aminoglycosides plus loop diuretics are synergistically toxic because both hit NKCC-expressing cells in the stria vascularis. Get those two concepts locked in and most loop diuretic questions become straightforward.

From real student decks
89%have cards covering this topic
62%have mature cards

Common misconceptions

Common mistake
Wrong: Loop diuretics block the Na/K-ATPase pump.
Right: Loop diuretics block the Na-K-2Cl cotransporter (NKCC2) on the apical membrane of the thick ascending limb of the loop of Henle.
Na/K-ATPase is on the basolateral membrane and powers the electrochemical gradients that drive secondary active transport — but it is not the loop diuretic target. Loop diuretics block NKCC2, a cotransporter on the apical (luminal) membrane of the thick ascending limb that uses the sodium gradient created by Na/K-ATPase to pull Na+, K+, and 2Cl- into the cell together. Think of Na/K-ATPase as the engine that fuels the system and NKCC2 as the door that actually gets blocked by furosemide.
Common mistake
Wrong: Loop diuretics spare calcium like thiazides do.
Right: Loop diuretics increase urinary calcium excretion (hypocalciuria does not occur; they are used to treat hypercalcemia), in contrast to thiazides which cause calcium retention.
This is one of the highest-yield distinctions in renal pharmacology. Thiazides cause hypocalciuria (calcium retention) by upregulating a basolateral calcium exchanger — they're used for calcium oxalate kidney stones. Loop diuretics do the opposite: they block NKCC2, which eliminates the positive lumen potential that normally drives paracellular calcium reabsorption in the TAL. The result is urinary calcium wasting (hypercalciuria), making loops the go-to treatment for hypercalcemia, not hypocalcemia.
Common mistake
Gap: Missing the mechanism and synergistic risk of ototoxicity with loop diuretics plus aminoglycosides
Loop diuretics cause dose-dependent ototoxicity (especially with concurrent aminoglycoside use) due to disruption of endolymph ion composition in the stria vascularis, which also expresses NKCC.
Ototoxicity from loop diuretics isn't random — it has a mechanistic basis. The stria vascularis of the cochlea uses NKCC1 (a related transporter) to maintain the high-K+ endolymph that hair cells need to detect sound. Loop diuretics disrupt this ion composition, damaging hair cells in a dose-dependent way. Aminoglycosides are independently ototoxic by a different mechanism (direct hair cell toxicity via free radicals), so combining them produces synergistic cochlear damage. If a Step 1 vignette shows a patient on furosemide who starts an aminoglycoside and develops tinnitus or hearing loss, that's the yield moment.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify NKCC2 as the specific transporter target of loop diuretics on the apical membrane of the thick ascending limb, and predict which ions are lost as a result (Na+, K+, Cl-, Mg2+, Ca2+).
  2. Recognize and explain each major adverse effect of loop diuretics using the OH DANG framework — including the mechanism behind ototoxicity and why co-administration with aminoglycosides is especially dangerous.
  3. Match the correct clinical scenario to loop diuretic use — pulmonary edema, acute decompensated heart failure, hypercalcemia, edema from cirrhosis or nephrotic syndrome — and distinguish when a loop diuretic is preferred over other diuretic classes.

Can you avoid these mistakes?

A patient with CHF is started on furosemide. Which transporter does this drug block, in which nephron segment, and name three electrolytes that will be wasted in the urine as a result?
A patient with hypercalcemia from malignancy is admitted. Would you use a loop diuretic or a thiazide to lower serum calcium — and why? What does this tell you about how each diuretic class handles calcium in the tubule?
A critically ill patient on furosemide is started on gentamicin for gram-negative sepsis. Three days later she reports hearing loss. What is the mechanism behind this complication, and what feature of the stria vascularis makes loop diuretics specifically dangerous here?
A patient on chronic furosemide therapy presents with weakness and EKG changes showing flattened T-waves. What electrolyte abnormality explains this, and which other loop diuretic adverse effect would you look for simultaneously given their mechanism of action?

Related topics

Loop of Henle Transport Kidney Development (Pro-/Meso-/Metanephros) Congenital Renal Anomalies Nephron Structure and Segments Renal Vasculature (Afferent / Efferent / Vasa Recta)

See how your Anki deck covers this topic.

Upload your deck for a free audit →